0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neutropenia Drugs Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-30Q9019
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Neutropenia Drugs Market Insights and Forecast to 2028

Global Neutropenia Drugs Market Insights and Forecast to 2028

Code: QYRE-Auto-30Q9019
Report
January 2022
108 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Neutropenia Drugs Market

Due to the COVID-19 pandemic, the global Neutropenia Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Capsule accounting for % of the Neutropenia Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.
China Neutropenia Drugs market size is valued at US$ million in 2021, while the US and Europe Neutropenia Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Neutropenia Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Neutropenia Drugs include Apotex Inc., Biogenomics Limited, Cellerant Therapeutics, Inc., Coherus BioSciences, Inc., Dr. Reddy’s Laboratories Limited, Ligand Pharmaceuticals, Inc., NAL Pharmaceuticals Ltd., Prolong Pharmaceuticals, LLC and Richter Gedeon Nyrt. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Neutropenia Drugs Scope and Segment
Neutropenia Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Neutropenia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Capsule
Injection

Segment by Application

Hospital
Clinic

BY COMPANY

Apotex Inc.
Biogenomics Limited
Cellerant Therapeutics, Inc.
Coherus BioSciences, Inc.
Dr. Reddy’s Laboratories Limited
Ligand Pharmaceuticals, Inc.
NAL Pharmaceuticals Ltd.
Prolong Pharmaceuticals, LLC
Richter Gedeon Nyrt.
Sandoz International GmbH

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Neutropenia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Neutropenia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Neutropenia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Neutropenia Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Neutropenia Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Neutropenia Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Neutropenia Drugs Sales by Region
2.4.1 Global Neutropenia Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Neutropenia Drugs by Region (2023-2028)
2.5 Global Neutropenia Drugs Revenue by Region
2.5.1 Global Neutropenia Drugs Revenue by Region (2017-2022)
2.5.2 Global Neutropenia Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neutropenia Drugs Sales by Manufacturers
3.1.1 Global Top Neutropenia Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Neutropenia Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neutropenia Drugs in 2021
3.2 Global Neutropenia Drugs Revenue by Manufacturers
3.2.1 Global Neutropenia Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Neutropenia Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Neutropenia Drugs Revenue in 2021
3.3 Global Neutropenia Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neutropenia Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neutropenia Drugs Sales by Type
4.1.1 Global Neutropenia Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Neutropenia Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Neutropenia Drugs Sales Market Share by Type (2017-2028)
4.2 Global Neutropenia Drugs Revenue by Type
4.2.1 Global Neutropenia Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Neutropenia Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Neutropenia Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Neutropenia Drugs Price by Type
4.3.1 Global Neutropenia Drugs Price by Type (2017-2022)
4.3.2 Global Neutropenia Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Neutropenia Drugs Sales by Application
5.1.1 Global Neutropenia Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Neutropenia Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Neutropenia Drugs Sales Market Share by Application (2017-2028)
5.2 Global Neutropenia Drugs Revenue by Application
5.2.1 Global Neutropenia Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Neutropenia Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Neutropenia Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Neutropenia Drugs Price by Application
5.3.1 Global Neutropenia Drugs Price by Application (2017-2022)
5.3.2 Global Neutropenia Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Neutropenia Drugs Market Size by Type
6.1.1 North America Neutropenia Drugs Sales by Type (2017-2028)
6.1.2 North America Neutropenia Drugs Revenue by Type (2017-2028)
6.2 North America Neutropenia Drugs Market Size by Application
6.2.1 North America Neutropenia Drugs Sales by Application (2017-2028)
6.2.2 North America Neutropenia Drugs Revenue by Application (2017-2028)
6.3 North America Neutropenia Drugs Market Size by Country
6.3.1 North America Neutropenia Drugs Sales by Country (2017-2028)
6.3.2 North America Neutropenia Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Neutropenia Drugs Market Size by Type
7.1.1 Europe Neutropenia Drugs Sales by Type (2017-2028)
7.1.2 Europe Neutropenia Drugs Revenue by Type (2017-2028)
7.2 Europe Neutropenia Drugs Market Size by Application
7.2.1 Europe Neutropenia Drugs Sales by Application (2017-2028)
7.2.2 Europe Neutropenia Drugs Revenue by Application (2017-2028)
7.3 Europe Neutropenia Drugs Market Size by Country
7.3.1 Europe Neutropenia Drugs Sales by Country (2017-2028)
7.3.2 Europe Neutropenia Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neutropenia Drugs Market Size by Type
8.1.1 Asia Pacific Neutropenia Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Neutropenia Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Neutropenia Drugs Market Size by Application
8.2.1 Asia Pacific Neutropenia Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Neutropenia Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Neutropenia Drugs Market Size by Region
8.3.1 Asia Pacific Neutropenia Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Neutropenia Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Neutropenia Drugs Market Size by Type
9.1.1 Latin America Neutropenia Drugs Sales by Type (2017-2028)
9.1.2 Latin America Neutropenia Drugs Revenue by Type (2017-2028)
9.2 Latin America Neutropenia Drugs Market Size by Application
9.2.1 Latin America Neutropenia Drugs Sales by Application (2017-2028)
9.2.2 Latin America Neutropenia Drugs Revenue by Application (2017-2028)
9.3 Latin America Neutropenia Drugs Market Size by Country
9.3.1 Latin America Neutropenia Drugs Sales by Country (2017-2028)
9.3.2 Latin America Neutropenia Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neutropenia Drugs Market Size by Type
10.1.1 Middle East and Africa Neutropenia Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Neutropenia Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Neutropenia Drugs Market Size by Application
10.2.1 Middle East and Africa Neutropenia Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Neutropenia Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Neutropenia Drugs Market Size by Country
10.3.1 Middle East and Africa Neutropenia Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Neutropenia Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Apotex Inc.
11.1.1 Apotex Inc. Corporation Information
11.1.2 Apotex Inc. Overview
11.1.3 Apotex Inc. Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Apotex Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Apotex Inc. Recent Developments
11.2 Biogenomics Limited
11.2.1 Biogenomics Limited Corporation Information
11.2.2 Biogenomics Limited Overview
11.2.3 Biogenomics Limited Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biogenomics Limited Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biogenomics Limited Recent Developments
11.3 Cellerant Therapeutics, Inc.
11.3.1 Cellerant Therapeutics, Inc. Corporation Information
11.3.2 Cellerant Therapeutics, Inc. Overview
11.3.3 Cellerant Therapeutics, Inc. Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cellerant Therapeutics, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cellerant Therapeutics, Inc. Recent Developments
11.4 Coherus BioSciences, Inc.
11.4.1 Coherus BioSciences, Inc. Corporation Information
11.4.2 Coherus BioSciences, Inc. Overview
11.4.3 Coherus BioSciences, Inc. Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Coherus BioSciences, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Coherus BioSciences, Inc. Recent Developments
11.5 Dr. Reddy’s Laboratories Limited
11.5.1 Dr. Reddy’s Laboratories Limited Corporation Information
11.5.2 Dr. Reddy’s Laboratories Limited Overview
11.5.3 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr. Reddy’s Laboratories Limited Recent Developments
11.6 Ligand Pharmaceuticals, Inc.
11.6.1 Ligand Pharmaceuticals, Inc. Corporation Information
11.6.2 Ligand Pharmaceuticals, Inc. Overview
11.6.3 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ligand Pharmaceuticals, Inc. Recent Developments
11.7 NAL Pharmaceuticals Ltd.
11.7.1 NAL Pharmaceuticals Ltd. Corporation Information
11.7.2 NAL Pharmaceuticals Ltd. Overview
11.7.3 NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 NAL Pharmaceuticals Ltd. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 NAL Pharmaceuticals Ltd. Recent Developments
11.8 Prolong Pharmaceuticals, LLC
11.8.1 Prolong Pharmaceuticals, LLC Corporation Information
11.8.2 Prolong Pharmaceuticals, LLC Overview
11.8.3 Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Prolong Pharmaceuticals, LLC Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Prolong Pharmaceuticals, LLC Recent Developments
11.9 Richter Gedeon Nyrt.
11.9.1 Richter Gedeon Nyrt. Corporation Information
11.9.2 Richter Gedeon Nyrt. Overview
11.9.3 Richter Gedeon Nyrt. Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Richter Gedeon Nyrt. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Richter Gedeon Nyrt. Recent Developments
11.10 Sandoz International GmbH
11.10.1 Sandoz International GmbH Corporation Information
11.10.2 Sandoz International GmbH Overview
11.10.3 Sandoz International GmbH Neutropenia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sandoz International GmbH Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sandoz International GmbH Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Neutropenia Drugs Industry Chain Analysis
12.2 Neutropenia Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neutropenia Drugs Production Mode & Process
12.4 Neutropenia Drugs Sales and Marketing
12.4.1 Neutropenia Drugs Sales Channels
12.4.2 Neutropenia Drugs Distributors
12.5 Neutropenia Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neutropenia Drugs Industry Trends
13.2 Neutropenia Drugs Market Drivers
13.3 Neutropenia Drugs Market Challenges
13.4 Neutropenia Drugs Market Restraints
14 Key Findings in The Global Neutropenia Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Neutropenia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Capsule
    Table 3. Major Manufacturers of Injection
    Table 4. Global Neutropenia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Neutropenia Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Neutropenia Drugs Sales by Region (2017-2022) & (K MT)
    Table 7. Global Neutropenia Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Neutropenia Drugs Sales by Region (2023-2028) & (K MT)
    Table 9. Global Neutropenia Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Neutropenia Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Neutropenia Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Neutropenia Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Neutropenia Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Neutropenia Drugs Sales by Manufacturers (2017-2022) & (K MT)
    Table 15. Global Neutropenia Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Neutropenia Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Neutropenia Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Neutropenia Drugs Price by Manufacturers (2017-2022) &(USD/MT)
    Table 19. Global Neutropenia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Neutropenia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Drugs as of 2021)
    Table 21. Neutropenia Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Neutropenia Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Neutropenia Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
    Table 26. Global Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
    Table 27. Global Neutropenia Drugs Sales Share by Type (2017-2022)
    Table 28. Global Neutropenia Drugs Sales Share by Type (2023-2028)
    Table 29. Global Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Neutropenia Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Neutropenia Drugs Revenue Share by Type (2023-2028)
    Table 33. Neutropenia Drugs Price by Type (2017-2022) & (USD/MT)
    Table 34. Global Neutropenia Drugs Price Forecast by Type (2023-2028) & (USD/MT)
    Table 35. Global Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
    Table 36. Global Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
    Table 37. Global Neutropenia Drugs Sales Share by Application (2017-2022)
    Table 38. Global Neutropenia Drugs Sales Share by Application (2023-2028)
    Table 39. Global Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Neutropenia Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Neutropenia Drugs Revenue Share by Application (2023-2028)
    Table 43. Neutropenia Drugs Price by Application (2017-2022) & (USD/MT)
    Table 44. Global Neutropenia Drugs Price Forecast by Application (2023-2028) & (USD/MT)
    Table 45. North America Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
    Table 46. North America Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
    Table 47. North America Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
    Table 50. North America Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
    Table 51. North America Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
    Table 54. North America Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
    Table 55. North America Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
    Table 58. Europe Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
    Table 59. Europe Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
    Table 62. Europe Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
    Table 63. Europe Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
    Table 66. Europe Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
    Table 67. Europe Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
    Table 70. Asia Pacific Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
    Table 71. Asia Pacific Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
    Table 74. Asia Pacific Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
    Table 75. Asia Pacific Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Neutropenia Drugs Sales by Region (2017-2022) & (K MT)
    Table 78. Asia Pacific Neutropenia Drugs Sales by Region (2023-2028) & (K MT)
    Table 79. Asia Pacific Neutropenia Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Neutropenia Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
    Table 82. Latin America Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
    Table 83. Latin America Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
    Table 86. Latin America Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
    Table 87. Latin America Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
    Table 90. Latin America Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
    Table 91. Latin America Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Neutropenia Drugs Sales by Type (2017-2022) & (K MT)
    Table 94. Middle East and Africa Neutropenia Drugs Sales by Type (2023-2028) & (K MT)
    Table 95. Middle East and Africa Neutropenia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Neutropenia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Neutropenia Drugs Sales by Application (2017-2022) & (K MT)
    Table 98. Middle East and Africa Neutropenia Drugs Sales by Application (2023-2028) & (K MT)
    Table 99. Middle East and Africa Neutropenia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Neutropenia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Neutropenia Drugs Sales by Country (2017-2022) & (K MT)
    Table 102. Middle East and Africa Neutropenia Drugs Sales by Country (2023-2028) & (K MT)
    Table 103. Middle East and Africa Neutropenia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Neutropenia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Apotex Inc. Corporation Information
    Table 106. Apotex Inc. Description and Major Businesses
    Table 107. Apotex Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 108. Apotex Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Apotex Inc. Recent Developments
    Table 110. Biogenomics Limited Corporation Information
    Table 111. Biogenomics Limited Description and Major Businesses
    Table 112. Biogenomics Limited Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. Biogenomics Limited Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Biogenomics Limited Recent Developments
    Table 115. Cellerant Therapeutics, Inc. Corporation Information
    Table 116. Cellerant Therapeutics, Inc. Description and Major Businesses
    Table 117. Cellerant Therapeutics, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 118. Cellerant Therapeutics, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Cellerant Therapeutics, Inc. Recent Developments
    Table 120. Coherus BioSciences, Inc. Corporation Information
    Table 121. Coherus BioSciences, Inc. Description and Major Businesses
    Table 122. Coherus BioSciences, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 123. Coherus BioSciences, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Coherus BioSciences, Inc. Recent Developments
    Table 125. Dr. Reddy’s Laboratories Limited Corporation Information
    Table 126. Dr. Reddy’s Laboratories Limited Description and Major Businesses
    Table 127. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Dr. Reddy’s Laboratories Limited Recent Developments
    Table 130. Ligand Pharmaceuticals, Inc. Corporation Information
    Table 131. Ligand Pharmaceuticals, Inc. Description and Major Businesses
    Table 132. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 133. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Ligand Pharmaceuticals, Inc. Recent Developments
    Table 135. NAL Pharmaceuticals Ltd. Corporation Information
    Table 136. NAL Pharmaceuticals Ltd. Description and Major Businesses
    Table 137. NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 138. NAL Pharmaceuticals Ltd. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. NAL Pharmaceuticals Ltd. Recent Developments
    Table 140. Prolong Pharmaceuticals, LLC Corporation Information
    Table 141. Prolong Pharmaceuticals, LLC Description and Major Businesses
    Table 142. Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 143. Prolong Pharmaceuticals, LLC Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Prolong Pharmaceuticals, LLC Recent Developments
    Table 145. Richter Gedeon Nyrt. Corporation Information
    Table 146. Richter Gedeon Nyrt. Description and Major Businesses
    Table 147. Richter Gedeon Nyrt. Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 148. Richter Gedeon Nyrt. Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Richter Gedeon Nyrt. Recent Developments
    Table 150. Sandoz International GmbH Corporation Information
    Table 151. Sandoz International GmbH Description and Major Businesses
    Table 152. Sandoz International GmbH Neutropenia Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 153. Sandoz International GmbH Neutropenia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Sandoz International GmbH Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Neutropenia Drugs Distributors List
    Table 158. Neutropenia Drugs Customers List
    Table 159. Neutropenia Drugs Market Trends
    Table 160. Neutropenia Drugs Market Drivers
    Table 161. Neutropenia Drugs Market Challenges
    Table 162. Neutropenia Drugs Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neutropenia Drugs Product Picture
    Figure 3. Global Neutropenia Drugs Market Share by Type in 2021 & 2028
    Figure 3. Capsule Product Picture
    Figure 4. Injection Product Picture
    Figure 5. Global Neutropenia Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Clinic
    Figure 8. Neutropenia Drugs Report Years Considered
    Figure 9. Global Neutropenia Drugs Sales 2017-2028 (K MT)
    Figure 10. Global Neutropenia Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Neutropenia Drugs Revenue 2017-2028 (US$ Million)
    Figure 12. Global Neutropenia Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Neutropenia Drugs Sales Market Share by Region (2017-2022)
    Figure 14. Global Neutropenia Drugs Sales Market Share by Region (2023-2028)
    Figure 15. North America Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
    Figure 16. North America Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
    Figure 18. Europe Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
    Figure 20. Asia-Pacific Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
    Figure 22. Latin America Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Neutropenia Drugs Sales YoY (2017-2028) & (K MT)
    Figure 24. Middle East & Africa Neutropenia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Neutropenia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Neutropenia Drugs in the World: Market Share by Neutropenia Drugs Revenue in 2021
    Figure 27. Global Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Neutropenia Drugs Sales Market Share by Type (2017-2028)
    Figure 29. Global Neutropenia Drugs Revenue Market Share by Type (2017-2028)
    Figure 30. Global Neutropenia Drugs Sales Market Share by Application (2017-2028)
    Figure 31. Global Neutropenia Drugs Revenue Market Share by Application (2017-2028)
    Figure 32. North America Neutropenia Drugs Sales Market Share by Type (2017-2028)
    Figure 33. North America Neutropenia Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. North America Neutropenia Drugs Sales Market Share by Application (2017-2028)
    Figure 35. North America Neutropenia Drugs Revenue Market Share by Application (2017-2028)
    Figure 36. North America Neutropenia Drugs Sales Share by Country (2017-2028)
    Figure 37. North America Neutropenia Drugs Revenue Share by Country (2017-2028)
    Figure 38. U.S. Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Neutropenia Drugs Sales Market Share by Type (2017-2028)
    Figure 41. Europe Neutropenia Drugs Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Neutropenia Drugs Sales Market Share by Application (2017-2028)
    Figure 43. Europe Neutropenia Drugs Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Neutropenia Drugs Sales Share by Country (2017-2028)
    Figure 45. Europe Neutropenia Drugs Revenue Share by Country (2017-2028)
    Figure 46. Germany Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 47. France Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Neutropenia Drugs Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Neutropenia Drugs Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Neutropenia Drugs Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Neutropenia Drugs Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Neutropenia Drugs Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Neutropenia Drugs Revenue Share by Region (2017-2028)
    Figure 57. China Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. India Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Neutropenia Drugs Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Neutropenia Drugs Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Neutropenia Drugs Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Neutropenia Drugs Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Neutropenia Drugs Sales Share by Country (2017-2028)
    Figure 72. Latin America Neutropenia Drugs Revenue Share by Country (2017-2028)
    Figure 73. Mexico Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Neutropenia Drugs Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Neutropenia Drugs Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Neutropenia Drugs Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Neutropenia Drugs Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Neutropenia Drugs Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Neutropenia Drugs Revenue Share by Country (2017-2028)
    Figure 82. Turkey Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Neutropenia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. Neutropenia Drugs Value Chain
    Figure 86. Neutropenia Drugs Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

Global Granisetron Hydrochloride API Market Insights Forecast to 2028
Global Granisetron Hydrochloride API Market Insights, Forecast to 2028

It is a raw material for nervous system and is used in the production of Tropisetron Hydrochloride.Market Analysis and Insights Global Granisetron Hydrochloride API MarketDue to the COVID19 pandemic the global Granisetron Hydrochloride API market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-35O10206
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Lab Scale Bioreactor Market Insights Forecast to 2028
Global Lab Scale Bioreactor Market Insights, Forecast to 2028

The small volume bioreactors enable the biomass growth extracellular metabolite production solidstate fermentation and biocatalytic processes in a controlled open system.Market Analysis and Insights Global Lab Scale Bioreactor MarketDue to the COVID19 pandemic the global Lab Scale Bioreactor market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-17O10483
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Ocular Excipients Market Insights Forecast to 2028
Global Ocular Excipients Market Insights, Forecast to 2028

Market Analysis and Insights Global Ocular Excipients MarketDue to the COVID19 pandemic the global Ocular Excipients market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-2T10675
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Barium Titanium Oxide Market Insights Forecast to 2028
Global Barium Titanium Oxide Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-9Z7409
Wed May 18 00:00:00 UTC 2022

Add to Cart